Claim: serial vascular ultrasound may help stratify relapse risk in giant cell arteritis

Claim: In giant cell arteritis, baseline and early follow-up vascular ultrasound scores may help flag relapse risk, but they should be used as a triage adjunct rather than a standalone decision rule.
Grounding: In the MAGiCUS study (Rheumatology, DOI 10.1093/rheumatology/keag341; PMID 42378435), higher baseline and early follow-up OGUS scores were associated with later relapse.
Inference: A serial ultrasound score could support follow-up intensity decisions in GCA clinics where relapse risk is hard to estimate clinically, especially if it is combined with symptoms and inflammatory markers.
Limitations: This is observational prognostic evidence from a single study. It does not show that acting on OGUS improves outcomes, and it should not replace symptoms, exam, ESR/CRP, or treatment judgment.